Intranasal vaccines represent a novel delivery system that gives drugmakers, providers, and patients additional options to choose from when making care decisions. Drugmakers need to consider formulations and manufacturing logistics from the beginning of the drug development pipeline in order to ensure the quickest market access. The current landscape of intranasal delivery systems will be discussed in a webinar tomorrow, June 29th.
According to Fierce Biotech, “In this webinar, experts will share insights into intranasal vaccine formulation development and discuss the current state of the art in intranasal vaccine production from development to commercial scale. In addition, a detailed discussion on the challenges and opportunities of intranasal approaches will be presented including the importance of device selection in determining product performance.”
To register, click here.
(Source: Fierce Biotech, June 28th, 2022)
